© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
November 21st 2019, 10:18pm
In partnership with the Australian Therapeutic Goods Administration (TGA) and Health Canada, the Food and Drug Administration (FDA) has granted supplemental approval to Calquence (acalabrutinib) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
May 15th 2019, 11:43pm
The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
November 29th 2018, 7:59pm
Take a look at the FDA’s decisions for the treatment of SLL that happened this year.
November 12th 2018, 11:17pm
Imbruvica (ibrutinib) is a safe treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), according to a pooled analysis of four clinical trials.
September 25th 2018, 12:00am
The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma.
Reducing Alcohol Consumption Leads to a ‘Plethora of Health Benefits’ Including Decreased Risk of Cancer, Expert Says
Women With Diabetes May Face Increased Kidney Cancer Risk
Common Questions on Medical Marijuana
Remission: Time to Breathe Again!